Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 9.84% vs 14.77% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 4,466.04% vs -92.08% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 23.97% vs -8.86% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 393.23% vs 13.70% in Mar 2025
Compare Profit and Loss Results of Vaishali Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
108.00
53.00
55.00
103.77%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
108.00
53.00
55.00
103.77%
Expenditure (Ex Depriciation)
Stock Adjustments
1.00
2.00
-1.00
-50.00%
Raw Materials Consumed
93.00
21.00
72.00
342.86%
Power & Fuel Cost
0.00
3.00
-3.00
-100.00%
Employee Cost
2.00
9.00
-7.00
-77.78%
Operating Expenses
0.00
7.00
-7.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
3.00
2.00
1.00
50.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
0.00
2.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
104.00
51.00
53.00
103.92%
Operating Profit (PBDIT) excl Other Income
4.00
2.00
2.00
100.00%
Other Income
3.00
9.00
-6.00
-66.67%
Operating Profit (PBDIT)
7.00
11.00
-4.00
-36.36%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
5.00
11.00
-6.00
-54.55%
Depreciation
0.00
2.00
-2.00
-100.00%
Profit Before Taxation & Exceptional Items
5.00
9.00
-4.00
-44.44%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
9.00
-4.00
-44.44%
Provision for Tax
1.00
2.00
-1.00
-50.00%
Profit After Tax
4.00
6.00
-2.00
-33.33%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
15.00
118.00
-103.00
-87.29%
Profit Available for appropriations
19.00
125.00
-106.00
-84.80%
Appropriations
19.00
125.00
-106.00
-84.80%
Equity Dividend (%)
0%
35%
-35.00
Earnings Per Share
0.31
6.7
-6.39
-95.37%
Profit And Loss - Net Sales
Net Sales 108.77 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 9.84% vs 14.77% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.11 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 4,466.04% vs -92.08% in Mar 2025
Profit And Loss - Interest
Interest 1.96 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 23.97% vs -8.86% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 4.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 393.23% vs 13.70% in Mar 2025
Footer loading
